ArticleNature plants2026
Occupancy-based mechanism is the chief mode of ROS1 function in preventing DNA hypermethylation.
Article in Nature plants, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA demethylation is essential for maintaining genome-wide DNA methylation balance. Despite the substantial risk to genome stability, the prevailing paradigm posits that the Arabidopsis demethylase ROS1 prevents genome-wide DNA hypermethylation in vivo mainly through its 5-methylcytosine DNA glycosylase/lyase activity. Here we challenge this paradigm by demonstrating that ROS1, through its occupancy, drives extensive passive demethylation independent of its glycosylase/lyase activity and maintains hypomethylation primarily by preventing de novo DNA methylation. This occupancy-based mechanism eliminates the need for genome-wide base excision for active demethylation, thereby minimizing threats to genomic fidelity and stability. Beyond its role in demethylation, ROS1 also functions as a key marker and regulator of chromatin accessibility. This regulation operates in both DNA methylation-dependent and -independent contexts, with ROS1 acting as either a reserve or active protector of accessible chromatin, depending on the functional state of DNA methylation systems. Our findings redefine the diverse roles of ROS1 in DNA methylation regulation and chromatin accessibility, highlighting their intricate interplay.
Indexed as
Identifiers
41927841What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.